首页 > 市场调查报告书 > 製药

生物製剂

市场调查报告书

商品编码

1801431

转换成长因子 Beta 1 市场报告：趋势、预测与竞争分析（至 2031 年）

Transforming Growth Factor Beta 1 Market Report: Trends, Forecast and Competitive Analysis to 2031

出版日期: 2025年08月29日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录图表

全球转化生长因子β1市场前景光明，得益于特发性肺纤维化（IPF）和癌症市场的机会。预计2025年至2031年期间，全球转化生长因子β1市场将以9.7%的复合年增长率成长。该市场的主要驱动力包括：对其在癌症治疗药物中应用的研究不断增加、全球纤维化疾病盛行率的上升，以及对生物製药开发的投资不断增加。

Lucintel 预测，在预测期内，Pirfenidone将在所有药物类别中实现最高的成长率。
从应用来看，肿瘤学预计将经历更高的成长。
按地区划分，预计亚太地区将在预测期内实现最高成长。

转换成长因子 Beta 1 市场的新趋势

随着生物技术的进步、临床研究的不断深入以及疾病治疗应用的不断拓展，转化生长因子β1市场正在不断发展。新兴趋势正在推动技术创新，并扩大市场潜力。

纤维化治疗日益受到关注：研发人员正在开发利用转化生长因子β1治疗纤维化疾病的标靶治疗。这一趋势正在拓展肝纤维化和肺纤维化等疾病的治疗选择。
癌症免疫疗法中的作用日益扩大：转化生长因子β1正被研究作为癌症治疗的靶点，同时新的抑制剂也正在研发中，以增强免疫疗法的有效性。这项研究或将催生新的抗癌药物。
再生医学的进展：转化生长因子-β1在组织工程和干细胞治疗的应用日益广泛。它在创伤治疗和器官再生中发挥着重要作用。
精准医疗的应用不断扩大：涉及调节转化生长因子-β1的个人化治疗正在出现，研究人员正在探索其在客製化自体免疫和发炎疾病治疗方法中的作用。
政府和私营部门的资金投入增加：生物技术研究投资的增加正在加速药物研发。政府和私人企业正在资助探索新医疗应用的计划。

这些趋势正在透过扩大治疗应用和提高治疗精度重塑转化生长因子β1市场，持续的研究和投资预计将推动进一步的技术创新。

转化成长因子β1市场的最新趋势

转化生长因子β1市场在临床研究、药物开发和监管核准方面正在取得重大进展。这些发展正在塑造治疗应用的未来。

抗癌药物的进展：研发人员正在开发转化生长因子β-1抑制剂，以增强免疫疗法。这些进展正在改善癌症治疗效果。
纤维化治疗研究取得进展：针对转化生长因子β1的药物正在进行针对肺纤维化和肝纤维化的临床试验，为治疗提供了新的可能性。
拓展再生医学的应用：探讨转化生长因子β1在干细胞治疗和组织再生中的作用，推动医学创新。
增加临床试验的监管核准：政府和卫生当局正在支持转化生长因子β-1的研究，从而带来更多的临床试验和新药核准。
扩大生物技术公司和大学之间的合作：产业合作伙伴关係正在加速转化生长因子-β1治疗方法的研究并促进创新。

这些市场发展正在透过扩大治疗应用和加速药物核准来改变转化生长因子β1市场。增加研究资金和合作研究正在推动市场成长。

The future of the global transforming growth factor beta 1 market looks promising with opportunities in the IPF and cancer markets. The global transforming growth factor beta 1 market is expected to grow with a CAGR of 9.7% from 2025 to 2031. The major drivers for this market are the increasing research in cancer therapeutics applications, the rising prevalence of fibrotic diseases globally, and the growing investment in biotechnology drug development.

Lucintel forecasts that, within the type category, pirfenidone is expected to witness higher growth over the forecast period.
Within the application category, cancer is expected to witness higher growth.
In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Transforming Growth Factor Beta 1 Market

The transforming growth factor beta 1 market is evolving with advancements in biotechnology, increased clinical research, and growing applications in disease treatment. Emerging trends are driving innovation and expanding market potential.

Increased Focus on Fibrosis Treatment: Researchers are developing targeted therapies using transforming growth factor beta 1 to manage fibrotic diseases. This trend is expanding treatment options for conditions such as liver fibrosis and pulmonary fibrosis.
Growing Role in Cancer Immunotherapy: Transforming growth factor beta 1 is being explored as a target in cancer treatment, with new inhibitors being developed to improve immunotherapy effectiveness. This research is leading to new oncology drugs.
Advancements in Regenerative Medicine: The use of transforming growth factor beta 1 in tissue engineering and stem cell therapy is growing. It is playing a crucial role in wound healing and organ regeneration.
Expansion in Precision Medicine Applications: Personalized therapies involving transforming growth factor beta 1 modulation are emerging. Researchers are exploring its role in tailoring treatments for autoimmune and inflammatory diseases.
Increasing Government and Private Sector Funding: Rising investments in biotechnology research are accelerating drug development. Governments and private firms are funding projects to explore new medical applications.

These trends are reshaping the transforming growth factor beta 1 market by expanding its therapeutic applications and enhancing treatment precision. Continued research and investment are expected to drive further innovations.

Recent Developments in the Transforming Growth Factor Beta 1 Market

The transforming growth factor beta 1 market is experiencing significant advancements in clinical research, drug development, and regulatory approvals. These developments are shaping the future of therapeutic applications.

Advancement in Cancer Therapeutics: Researchers are developing transforming growth factor beta 1 inhibitors to enhance immunotherapy. These advancements are improving cancer treatment outcomes.
Progress in Fibrosis Treatment Research: Clinical trials are evaluating transforming growth factor beta 1-targeted drugs for pulmonary and liver fibrosis, offering new treatment possibilities.
Expansion of Regenerative Medicine Applications: Scientists are exploring transforming growth factor beta 1's role in stem cell therapy and tissue regeneration, advancing medical innovation.
Increased Regulatory Approvals for Clinical Trials: Governments and health authorities are supporting research on transforming growth factor beta 1, leading to more clinical trials and new drug approvals.
Growing Collaborations Between Biotech Companies and Universities: Industry partnerships are accelerating research, driving innovation in transforming growth factor beta 1-based therapies.

These developments are transforming the transforming growth factor beta 1 market by expanding its therapeutic applications and accelerating drug approvals. Increased research funding and collaborations are driving market growth.

Strategic Growth Opportunities in the Transforming Growth Factor Beta 1 Market

The transforming growth factor beta 1 market presents significant growth opportunities across various applications. Advancements in regenerative medicine, oncology, and fibrosis treatment are creating new possibilities for market expansion.

Development of Anti-Fibrotic Therapies: The rising prevalence of fibrotic diseases is driving demand for transforming growth factor beta 1 inhibitors, offering new market opportunities in pulmonary and liver fibrosis treatment.
Expansion in Cancer Immunotherapy Research: Transforming growth factor beta 1 modulation is improving immunotherapy outcomes, creating opportunities for new oncology drug development.
Advancements in Stem Cell Therapy Applications: The integration of transforming growth factor beta 1 in stem cell-based treatments is enhancing wound healing and tissue regeneration.
Increasing Use in Autoimmune Disease Treatment: Researchers are exploring the role of transforming growth factor beta 1 in regulating immune responses, creating growth potential in autoimmune therapy.
Growing Investment in Personalized Medicine: The role of transforming growth factor beta 1 in precision medicine is expanding, allowing for the development of targeted therapies for specific patient populations.

These growth opportunities highlight the expanding role of transforming growth factor beta 1 in modern medicine. Continued research and investment are expected to drive innovation and broaden its therapeutic applications.

Transforming Growth Factor Beta 1 Market Driver and Challenges

The transforming growth factor beta 1 market is influenced by various drivers and challenges, including advancements in medical research, regulatory policies, and economic factors. These elements shape the market's growth and application potential.

The factors responsible for driving the transforming growth factor beta 1 market include:

1. Rising Demand for Regenerative Medicine: Increasing interest in tissue engineering and stem cell therapy is driving the demand for transforming growth factor beta 1 in regenerative medicine applications.

2. Growing Investments in Oncology Research: Pharmaceutical companies are funding research on transforming growth factor beta 1 inhibitors for cancer treatment, expanding market opportunities.

3. Advancements in Drug Development Technologies: Innovations in biotechnology are enabling the development of targeted therapies using transforming growth factor beta 1, improving treatment effectiveness.

4. Supportive Government Policies for Biotechnology Research: Governments worldwide are funding biotechnology projects, accelerating research on transforming growth factor beta 1 applications.

5. Expansion of Clinical Trials in Fibrosis and Cancer Therapy: Increasing clinical trials exploring transforming growth factor beta 1's role in disease treatment are driving market growth and drug development.

Challenges in the transforming growth factor beta 1 market are:

1. Regulatory Complexities and Approval Delays: The stringent approval process for new transforming growth factor beta 1 therapies poses a challenge to market entry and commercialization.

2. High Research and Development Costs: The cost-intensive nature of transforming growth factor beta 1 research limits investment by smaller biotech firms, slowing market expansion.

3. Potential Side Effects and Safety Concerns: Managing the adverse effects of transforming growth factor beta 1 modulation in therapeutic applications remains a significant challenge in drug development.

The transforming growth factor beta 1 market is growing due to increased research, regulatory support, and advancements in medical applications. However, challenges such as regulatory hurdles, high costs, and safety concerns must be addressed for sustained market growth.

List of Transforming Growth Factor Beta 1 Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies transforming growth factor beta 1 companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the transforming growth factor beta 1 companies profiled in this report include-

Roche
Shionogi
Acceleron Pharma
Genzyme
Isarna Therapeutics
Scholar Rock
Sirnaomics

Transforming Growth Factor Beta 1 Market by Segment

The study includes a forecast for the global transforming growth factor beta 1 market by type, application, and region.

Transforming Growth Factor Beta 1 Market by Type [Value from 2019 to 2031]:

Pirfenidone
Galunisertib
Others

Transforming Growth Factor Beta 1 Market by Application [Value from 2019 to 2031]:

IPF
Cancer
Others

Transforming Growth Factor Beta 1 Market by Region [Value from 2019 to 2031]:

North America
Europe
Asia Pacific
The Rest of the World

Country Wise Outlook for the Transforming Growth Factor Beta 1 Market

Increased Focus on Fibrosis Treatment: Researchers are developing targeted therapies using transforming growth factor beta 1 to manage fibrotic diseases. This trend is expanding treatment options for conditions such as liver fibrosis and pulmonary fibrosis.
Growing Role in Cancer Immunotherapy: Transforming growth factor beta 1 is being explored as a target in cancer treatment, with new inhibitors being developed to improve immunotherapy effectiveness. This research is leading to new oncology drugs.
Advancements in Regenerative Medicine: The use of transforming growth factor beta 1 in tissue engineering and stem cell therapy is growing. It is playing a crucial role in wound healing and organ regeneration.
Expansion in Precision Medicine Applications: Personalized therapies involving transforming growth factor beta 1 modulation are emerging. Researchers are exploring its role in tailoring treatments for autoimmune and inflammatory diseases.
Increasing Government and Private Sector Funding: Rising investments in biotechnology research are accelerating drug development. Governments and private firms are funding projects to explore new medical applications.

Features of the Global Transforming Growth Factor Beta 1 Market

Market Size Estimates: Transforming growth factor beta 1 market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Transforming growth factor beta 1 market size by type, application, and region in terms of value ($B).
Regional Analysis: Transforming growth factor beta 1 market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the transforming growth factor beta 1 market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the transforming growth factor beta 1 market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the transforming growth factor beta 1 market by type (pirfenidone, galunisertib, and others), application (IPF, cancer, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Market Overview

2.1 Background and Classifications
2.2 Supply Chain

3. Market Trends & Forecast Analysis

3.1 Macroeconomic Trends and Forecasts
3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment

4. Global Transforming Growth Factor Beta 1 Market by Type

4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 Pirfenidone: Trends and Forecast (2019-2031)
4.4 Galunisertib: Trends and Forecast (2019-2031)
4.5 Others: Trends and Forecast (2019-2031)

5. Global Transforming Growth Factor Beta 1 Market by Application

5.1 Overview
5.2 Attractiveness Analysis by Application
5.3 IPF: Trends and Forecast (2019-2031)
5.4 Cancer: Trends and Forecast (2019-2031)
5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

6.1 Overview
6.2 Global Transforming Growth Factor Beta 1 Market by Region

7. North American Transforming Growth Factor Beta 1 Market

7.1 Overview
7.2 North American Transforming Growth Factor Beta 1 Market by Type
7.3 North American Transforming Growth Factor Beta 1 Market by Application
7.4 United States Transforming Growth Factor Beta 1 Market
7.5 Mexican Transforming Growth Factor Beta 1 Market
7.6 Canadian Transforming Growth Factor Beta 1 Market

8. European Transforming Growth Factor Beta 1 Market

8.1 Overview
8.2 European Transforming Growth Factor Beta 1 Market by Type
8.3 European Transforming Growth Factor Beta 1 Market by Application
8.4 German Transforming Growth Factor Beta 1 Market
8.5 French Transforming Growth Factor Beta 1 Market
8.6 Spanish Transforming Growth Factor Beta 1 Market
8.7 Italian Transforming Growth Factor Beta 1 Market
8.8 United Kingdom Transforming Growth Factor Beta 1 Market

9. APAC Transforming Growth Factor Beta 1 Market

9.1 Overview
9.2 APAC Transforming Growth Factor Beta 1 Market by Type
9.3 APAC Transforming Growth Factor Beta 1 Market by Application
9.4 Japanese Transforming Growth Factor Beta 1 Market
9.5 Indian Transforming Growth Factor Beta 1 Market
9.6 Chinese Transforming Growth Factor Beta 1 Market
9.7 South Korean Transforming Growth Factor Beta 1 Market
9.8 Indonesian Transforming Growth Factor Beta 1 Market

10. ROW Transforming Growth Factor Beta 1 Market

10.1 Overview
10.2 ROW Transforming Growth Factor Beta 1 Market by Type
10.3 ROW Transforming Growth Factor Beta 1 Market by Application
10.4 Middle Eastern Transforming Growth Factor Beta 1 Market
10.5 South American Transforming Growth Factor Beta 1 Market
10.6 African Transforming Growth Factor Beta 1 Market

11. Competitor Analysis

11.1 Product Portfolio Analysis
11.2 Operational Integration
11.3 Porter's Five Forces Analysis
- Competitive Rivalry
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Threat of Substitutes
- Threat of New Entrants
11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

12.1 Value Chain Analysis
12.2 Growth Opportunity Analysis
- 12.2.1 Growth Opportunities by Type
- 12.2.2 Growth Opportunities by Application
12.3 Emerging Trends in the Global Transforming Growth Factor Beta 1 Market
12.4 Strategic Analysis
- 12.4.1 New Product Development
- 12.4.2 Certification and Licensing
- 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

13.1 Competitive Analysis
13.2 Roche
- Company Overview
- Transforming Growth Factor Beta 1 Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.3 Shionogi
- Company Overview
- Transforming Growth Factor Beta 1 Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.4 Acceleron Pharma
- Company Overview
- Transforming Growth Factor Beta 1 Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.5 Genzyme
- Company Overview
- Transforming Growth Factor Beta 1 Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.6 Isarna Therapeutics
- Company Overview
- Transforming Growth Factor Beta 1 Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.7 Scholar Rock
- Company Overview
- Transforming Growth Factor Beta 1 Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.8 Sirnaomics
- Company Overview
- Transforming Growth Factor Beta 1 Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing

14. Appendix

14.1 List of Figures
14.2 List of Tables
14.3 Research Methodology
14.4 Disclaimer
14.5 Copyright
14.6 Abbreviations and Technical Units
14.7 About Us
14.8 Contact Us

简介目录图表

List of Figures

Figure 1.1: Trends and Forecast for the Global Transforming Growth Factor Beta 1 Market
Figure 2.1: Usage of Transforming Growth Factor Beta 1 Market
Figure 2.2: Classification of the Global Transforming Growth Factor Beta 1 Market
Figure 2.3: Supply Chain of the Global Transforming Growth Factor Beta 1 Market
Figure 2.4: Driver and Challenges of the Transforming Growth Factor Beta 1 Market
Figure 3.1: Trends of the Global GDP Growth Rate
Figure 3.2: Trends of the Global Population Growth Rate
Figure 3.3: Trends of the Global Inflation Rate
Figure 3.4: Trends of the Global Unemployment Rate
Figure 3.5: Trends of the Regional GDP Growth Rate
Figure 3.6: Trends of the Regional Population Growth Rate
Figure 3.7: Trends of the Regional Inflation Rate
Figure 3.8: Trends of the Regional Unemployment Rate
Figure 3.9: Trends of Regional Per Capita Income
Figure 3.10: Forecast for the Global GDP Growth Rate
Figure 3.11: Forecast for the Global Population Growth Rate
Figure 3.12: Forecast for the Global Inflation Rate
Figure 3.13: Forecast for the Global Unemployment Rate
Figure 3.14: Forecast for the Regional GDP Growth Rate
Figure 3.15: Forecast for the Regional Population Growth Rate
Figure 3.16: Forecast for the Regional Inflation Rate
Figure 3.17: Forecast for the Regional Unemployment Rate
Figure 3.18: Forecast for Regional Per Capita Income
Figure 4.1: Global Transforming Growth Factor Beta 1 Market by Type in 2019, 2024, and 2031
Figure 4.2: Trends of the Global Transforming Growth Factor Beta 1 Market ($B) by Type
Figure 4.3: Forecast for the Global Transforming Growth Factor Beta 1 Market ($B) by Type
Figure 4.4: Trends and Forecast for Pirfenidone in the Global Transforming Growth Factor Beta 1 Market (2019-2031)
Figure 4.5: Trends and Forecast for Galunisertib in the Global Transforming Growth Factor Beta 1 Market (2019-2031)
Figure 4.6: Trends and Forecast for Others in the Global Transforming Growth Factor Beta 1 Market (2019-2031)
Figure 5.1: Global Transforming Growth Factor Beta 1 Market by Application in 2019, 2024, and 2031
Figure 5.2: Trends of the Global Transforming Growth Factor Beta 1 Market ($B) by Application
Figure 5.3: Forecast for the Global Transforming Growth Factor Beta 1 Market ($B) by Application
Figure 5.4: Trends and Forecast for IPF in the Global Transforming Growth Factor Beta 1 Market (2019-2031)
Figure 5.5: Trends and Forecast for Cancer in the Global Transforming Growth Factor Beta 1 Market (2019-2031)
Figure 5.6: Trends and Forecast for Others in the Global Transforming Growth Factor Beta 1 Market (2019-2031)
Figure 6.1: Trends of the Global Transforming Growth Factor Beta 1 Market ($B) by Region (2019-2024)
Figure 6.2: Forecast for the Global Transforming Growth Factor Beta 1 Market ($B) by Region (2025-2031)
Figure 7.1: Trends and Forecast for the North American Transforming Growth Factor Beta 1 Market (2019-2031)
Figure 7.2: North American Transforming Growth Factor Beta 1 Market by Type in 2019, 2024, and 2031
Figure 7.3: Trends of the North American Transforming Growth Factor Beta 1 Market ($B) by Type (2019-2024)
Figure 7.4: Forecast for the North American Transforming Growth Factor Beta 1 Market ($B) by Type (2025-2031)
Figure 7.5: North American Transforming Growth Factor Beta 1 Market by Application in 2019, 2024, and 2031
Figure 7.6: Trends of the North American Transforming Growth Factor Beta 1 Market ($B) by Application (2019-2024)
Figure 7.7: Forecast for the North American Transforming Growth Factor Beta 1 Market ($B) by Application (2025-2031)
Figure 7.8: Trends and Forecast for the United States Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
Figure 7.9: Trends and Forecast for the Mexican Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
Figure 7.10: Trends and Forecast for the Canadian Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
Figure 8.1: Trends and Forecast for the European Transforming Growth Factor Beta 1 Market (2019-2031)
Figure 8.2: European Transforming Growth Factor Beta 1 Market by Type in 2019, 2024, and 2031
Figure 8.3: Trends of the European Transforming Growth Factor Beta 1 Market ($B) by Type (2019-2024)
Figure 8.4: Forecast for the European Transforming Growth Factor Beta 1 Market ($B) by Type (2025-2031)
Figure 8.5: European Transforming Growth Factor Beta 1 Market by Application in 2019, 2024, and 2031
Figure 8.6: Trends of the European Transforming Growth Factor Beta 1 Market ($B) by Application (2019-2024)
Figure 8.7: Forecast for the European Transforming Growth Factor Beta 1 Market ($B) by Application (2025-2031)
Figure 8.8: Trends and Forecast for the German Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
Figure 8.9: Trends and Forecast for the French Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
Figure 8.10: Trends and Forecast for the Spanish Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
Figure 8.11: Trends and Forecast for the Italian Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
Figure 8.12: Trends and Forecast for the United Kingdom Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
Figure 9.1: Trends and Forecast for the APAC Transforming Growth Factor Beta 1 Market (2019-2031)
Figure 9.2: APAC Transforming Growth Factor Beta 1 Market by Type in 2019, 2024, and 2031
Figure 9.3: Trends of the APAC Transforming Growth Factor Beta 1 Market ($B) by Type (2019-2024)
Figure 9.4: Forecast for the APAC Transforming Growth Factor Beta 1 Market ($B) by Type (2025-2031)
Figure 9.5: APAC Transforming Growth Factor Beta 1 Market by Application in 2019, 2024, and 2031
Figure 9.6: Trends of the APAC Transforming Growth Factor Beta 1 Market ($B) by Application (2019-2024)
Figure 9.7: Forecast for the APAC Transforming Growth Factor Beta 1 Market ($B) by Application (2025-2031)
Figure 9.8: Trends and Forecast for the Japanese Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
Figure 9.9: Trends and Forecast for the Indian Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
Figure 9.10: Trends and Forecast for the Chinese Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
Figure 9.11: Trends and Forecast for the South Korean Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
Figure 9.12: Trends and Forecast for the Indonesian Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
Figure 10.1: Trends and Forecast for the ROW Transforming Growth Factor Beta 1 Market (2019-2031)
Figure 10.2: ROW Transforming Growth Factor Beta 1 Market by Type in 2019, 2024, and 2031
Figure 10.3: Trends of the ROW Transforming Growth Factor Beta 1 Market ($B) by Type (2019-2024)
Figure 10.4: Forecast for the ROW Transforming Growth Factor Beta 1 Market ($B) by Type (2025-2031)
Figure 10.5: ROW Transforming Growth Factor Beta 1 Market by Application in 2019, 2024, and 2031
Figure 10.6: Trends of the ROW Transforming Growth Factor Beta 1 Market ($B) by Application (2019-2024)
Figure 10.7: Forecast for the ROW Transforming Growth Factor Beta 1 Market ($B) by Application (2025-2031)
Figure 10.8: Trends and Forecast for the Middle Eastern Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
Figure 10.9: Trends and Forecast for the South American Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
Figure 10.10: Trends and Forecast for the African Transforming Growth Factor Beta 1 Market ($B) (2019-2031)
Figure 11.1: Porter's Five Forces Analysis of the Global Transforming Growth Factor Beta 1 Market
Figure 11.2: Market Share (%) of Top Players in the Global Transforming Growth Factor Beta 1 Market (2024)
Figure 12.1: Growth Opportunities for the Global Transforming Growth Factor Beta 1 Market by Type
Figure 12.2: Growth Opportunities for the Global Transforming Growth Factor Beta 1 Market by Application
Figure 12.3: Growth Opportunities for the Global Transforming Growth Factor Beta 1 Market by Region
Figure 12.4: Emerging Trends in the Global Transforming Growth Factor Beta 1 Market

List of Tables

Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Transforming Growth Factor Beta 1 Market by Type and Application
Table 1.2: Attractiveness Analysis for the Transforming Growth Factor Beta 1 Market by Region
Table 1.3: Global Transforming Growth Factor Beta 1 Market Parameters and Attributes
Table 3.1: Trends of the Global Transforming Growth Factor Beta 1 Market (2019-2024)
Table 3.2: Forecast for the Global Transforming Growth Factor Beta 1 Market (2025-2031)
Table 4.1: Attractiveness Analysis for the Global Transforming Growth Factor Beta 1 Market by Type
Table 4.2: Market Size and CAGR of Various Type in the Global Transforming Growth Factor Beta 1 Market (2019-2024)
Table 4.3: Market Size and CAGR of Various Type in the Global Transforming Growth Factor Beta 1 Market (2025-2031)
Table 4.4: Trends of Pirfenidone in the Global Transforming Growth Factor Beta 1 Market (2019-2024)
Table 4.5: Forecast for Pirfenidone in the Global Transforming Growth Factor Beta 1 Market (2025-2031)
Table 4.6: Trends of Galunisertib in the Global Transforming Growth Factor Beta 1 Market (2019-2024)
Table 4.7: Forecast for Galunisertib in the Global Transforming Growth Factor Beta 1 Market (2025-2031)
Table 4.8: Trends of Others in the Global Transforming Growth Factor Beta 1 Market (2019-2024)
Table 4.9: Forecast for Others in the Global Transforming Growth Factor Beta 1 Market (2025-2031)
Table 5.1: Attractiveness Analysis for the Global Transforming Growth Factor Beta 1 Market by Application
Table 5.2: Market Size and CAGR of Various Application in the Global Transforming Growth Factor Beta 1 Market (2019-2024)
Table 5.3: Market Size and CAGR of Various Application in the Global Transforming Growth Factor Beta 1 Market (2025-2031)
Table 5.4: Trends of IPF in the Global Transforming Growth Factor Beta 1 Market (2019-2024)
Table 5.5: Forecast for IPF in the Global Transforming Growth Factor Beta 1 Market (2025-2031)
Table 5.6: Trends of Cancer in the Global Transforming Growth Factor Beta 1 Market (2019-2024)
Table 5.7: Forecast for Cancer in the Global Transforming Growth Factor Beta 1 Market (2025-2031)
Table 5.8: Trends of Others in the Global Transforming Growth Factor Beta 1 Market (2019-2024)
Table 5.9: Forecast for Others in the Global Transforming Growth Factor Beta 1 Market (2025-2031)
Table 6.1: Market Size and CAGR of Various Regions in the Global Transforming Growth Factor Beta 1 Market (2019-2024)
Table 6.2: Market Size and CAGR of Various Regions in the Global Transforming Growth Factor Beta 1 Market (2025-2031)
Table 7.1: Trends of the North American Transforming Growth Factor Beta 1 Market (2019-2024)
Table 7.2: Forecast for the North American Transforming Growth Factor Beta 1 Market (2025-2031)
Table 7.3: Market Size and CAGR of Various Type in the North American Transforming Growth Factor Beta 1 Market (2019-2024)
Table 7.4: Market Size and CAGR of Various Type in the North American Transforming Growth Factor Beta 1 Market (2025-2031)
Table 7.5: Market Size and CAGR of Various Application in the North American Transforming Growth Factor Beta 1 Market (2019-2024)
Table 7.6: Market Size and CAGR of Various Application in the North American Transforming Growth Factor Beta 1 Market (2025-2031)
Table 7.7: Trends and Forecast for the United States Transforming Growth Factor Beta 1 Market (2019-2031)
Table 7.8: Trends and Forecast for the Mexican Transforming Growth Factor Beta 1 Market (2019-2031)
Table 7.9: Trends and Forecast for the Canadian Transforming Growth Factor Beta 1 Market (2019-2031)
Table 8.1: Trends of the European Transforming Growth Factor Beta 1 Market (2019-2024)
Table 8.2: Forecast for the European Transforming Growth Factor Beta 1 Market (2025-2031)
Table 8.3: Market Size and CAGR of Various Type in the European Transforming Growth Factor Beta 1 Market (2019-2024)
Table 8.4: Market Size and CAGR of Various Type in the European Transforming Growth Factor Beta 1 Market (2025-2031)
Table 8.5: Market Size and CAGR of Various Application in the European Transforming Growth Factor Beta 1 Market (2019-2024)
Table 8.6: Market Size and CAGR of Various Application in the European Transforming Growth Factor Beta 1 Market (2025-2031)
Table 8.7: Trends and Forecast for the German Transforming Growth Factor Beta 1 Market (2019-2031)
Table 8.8: Trends and Forecast for the French Transforming Growth Factor Beta 1 Market (2019-2031)
Table 8.9: Trends and Forecast for the Spanish Transforming Growth Factor Beta 1 Market (2019-2031)
Table 8.10: Trends and Forecast for the Italian Transforming Growth Factor Beta 1 Market (2019-2031)
Table 8.11: Trends and Forecast for the United Kingdom Transforming Growth Factor Beta 1 Market (2019-2031)
Table 9.1: Trends of the APAC Transforming Growth Factor Beta 1 Market (2019-2024)
Table 9.2: Forecast for the APAC Transforming Growth Factor Beta 1 Market (2025-2031)
Table 9.3: Market Size and CAGR of Various Type in the APAC Transforming Growth Factor Beta 1 Market (2019-2024)
Table 9.4: Market Size and CAGR of Various Type in the APAC Transforming Growth Factor Beta 1 Market (2025-2031)
Table 9.5: Market Size and CAGR of Various Application in the APAC Transforming Growth Factor Beta 1 Market (2019-2024)
Table 9.6: Market Size and CAGR of Various Application in the APAC Transforming Growth Factor Beta 1 Market (2025-2031)
Table 9.7: Trends and Forecast for the Japanese Transforming Growth Factor Beta 1 Market (2019-2031)
Table 9.8: Trends and Forecast for the Indian Transforming Growth Factor Beta 1 Market (2019-2031)
Table 9.9: Trends and Forecast for the Chinese Transforming Growth Factor Beta 1 Market (2019-2031)
Table 9.10: Trends and Forecast for the South Korean Transforming Growth Factor Beta 1 Market (2019-2031)
Table 9.11: Trends and Forecast for the Indonesian Transforming Growth Factor Beta 1 Market (2019-2031)
Table 10.1: Trends of the ROW Transforming Growth Factor Beta 1 Market (2019-2024)
Table 10.2: Forecast for the ROW Transforming Growth Factor Beta 1 Market (2025-2031)
Table 10.3: Market Size and CAGR of Various Type in the ROW Transforming Growth Factor Beta 1 Market (2019-2024)
Table 10.4: Market Size and CAGR of Various Type in the ROW Transforming Growth Factor Beta 1 Market (2025-2031)
Table 10.5: Market Size and CAGR of Various Application in the ROW Transforming Growth Factor Beta 1 Market (2019-2024)
Table 10.6: Market Size and CAGR of Various Application in the ROW Transforming Growth Factor Beta 1 Market (2025-2031)
Table 10.7: Trends and Forecast for the Middle Eastern Transforming Growth Factor Beta 1 Market (2019-2031)
Table 10.8: Trends and Forecast for the South American Transforming Growth Factor Beta 1 Market (2019-2031)
Table 10.9: Trends and Forecast for the African Transforming Growth Factor Beta 1 Market (2019-2031)
Table 11.1: Product Mapping of Transforming Growth Factor Beta 1 Suppliers Based on Segments
Table 11.2: Operational Integration of Transforming Growth Factor Beta 1 Manufacturers
Table 11.3: Rankings of Suppliers Based on Transforming Growth Factor Beta 1 Revenue
Table 12.1: New Product Launches by Major Transforming Growth Factor Beta 1 Producers (2019-2024)
Table 12.2: Certification Acquired by Major Competitor in the Global Transforming Growth Factor Beta 1 Market

02-2729-4219

+886-2-2729-4219

License/价格

FAQ

转换成长因子 Beta 1 市场报告：趋势、预测与竞争分析（至 2031 年）

Transforming Growth Factor Beta 1 Market Report: Trends, Forecast and Competitive Analysis to 2031

目录

第一章执行摘要

第二章 市场概述

第三章：市场趋势与预测分析

4. 全球转化成长因子β1市场（按类型）

5. 全球转化生长因子β1市场（依应用）

第六章区域分析

7. 北美转化生长因子β1市场

8. 欧洲转化成长因子β1市场

9. 亚太地区转化成长因子β1市场

10. 其他地区（ROW）的转化生长因子 β1 市场

第十一章 竞争分析

第十二章机会与策略分析

第十三章 价值链主要企业概况

第十四章 附录